Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Oncotarget|November 27, 2014
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomasLorena Landuzzi, Marianna L Ianzano, Giordano Nicoletti, et al.
Plos Pathogens|February 6, 2013
Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirusPatrizia Nanni, Valentina Gatta, Laura Menotti, et al.
Journal of Translational Medicine|January 30, 2025
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinomaLaura Scalambra, Francesca Ruzzi, Olga Maria Pittino, et al.
Oncogenesis|November 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progressionVeronica Giusti, Francesca Ruzzi, Lorena Landuzzi, et al.
International Journal of Cancer|February 10, 2007
Inhibition of prostate carcinogenesis by combined active immunoprophylaxisCarla De Giovanni, Stefania Croci, Giordano Nicoletti, et al.
Human Molecular Genetics|October 29, 2013
Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairmentLuisa Iommarini, Ivana Kurelac, Mariantonietta Capristo, et al.
Plos One|June 28, 2012
Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitorPatrizia Nanni, Giordano Nicoletti, Arianna Palladini, et al.
Molecular Cancer Therapeutics|July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyMaria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2009
High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapyPatrizia Nanni, Giordano Nicoletti, Lorena Landuzzi, et al.
Cancer Research|August 20, 2011
A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus functionGiuseppe Gasparre, Ivana Kurelac, Mariantonietta Capristo, et al.
Pageof 8